Clinical Trials Browser

Phase 2 × Sitagliptin Phosphate × Clear all

Brain Neoplasms, Glioblastoma

NCT01720264 2019-01-08

Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

LymphoidMyeloidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00862719 2016-10-07

Sitagliptin Umbilical Cord Blood Transplant Study

Phase 2 Completed

29 enrolled 15 charts

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Lymphoma, Non-Hodgkin, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas

Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

Sitagliptin Umbilical Cord Blood Transplant Study